BioSpace News Archive

Researchers with the Georgia Institute of Technology recently published work that describes several new approaches to improving CAR-T, particularly for solid tumors.

Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company received notice of a Product Development Research award totaling approximately $13.1 million.

Kadmon Holdings, Inc. announced that REZUROCK™ 200 mg once daily tablets is now commercially available for shipment to prescribed patients in the United States.

eQcell Inc. announces the initiation of two blinded, randomized trials in equine osteoarthritis at the University of Guelph’s Ontario Veterinary College Equine Sports Medicine and Reproductive Centre as well as at the University of California, Davis Veterinary Institute for Regenerative Cures.

Vitro Biopharma, Inc. announced the signing of a contract with European Wellness Biomedical Group headquartered in Kuala Lumpur, Malaysia and it’s start-up subsidiary BioPep being registered in Delaware, USA to develop FDA-approval of biological products derived from existing mitochondrial peptide extracts

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

Rising incidences of chronic diseases, extensive demand for early diagnosis and treatment of various diseases and disorders coupled with the need to enhance the quality of healthcare will invite substantial growth prospects for the multiparameter patient monitoring systems market during the forecast period of 2020-2030.

Noteworthy growth in the incidences of neurological disorders and autoimmune diseases across the globe is projected to help in the expansion of the global intravenous immunoglobulin market, according to a new study published by TMR.

Transparency Market Research has recently published a new research report that talks about the overall landscape of the global empty capsules market.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global vaccine management solution market was valued at US$ 140 million in 2019.